Company / Net Income
Arcus Biosciences, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$353.0M
FY2025
5-year range
-$353.0M / $53.0M
FY2021-FY2025
Trend
-24.7%
vs FY2024
Sector context
#186 of 216
Health Care
What the data says
Arcus Biosciences, Inc.'s net income of -$353M is lower than 86% of companies in the Health Care sector (FY2025). Net Income has fluctuated over the past 10 years, ranging from -$353M in FY2025 to $53M in FY2021.
Based on SEC 10-K filings.
-$353M in FY2025.
Declined from -$307M to -$353M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 216This company -$353.0M Sector average $454.3M
▼
-177.7% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 24.7% year-over-year.
- Ranks #186 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$353.0M | -24.7% |
| FY2024 | -$283.0M | +7.8% |
| FY2023 | -$307.0M | -149.6% |
| FY2022 | -$123.0M | -332.1% |
| FY2021 | $53.0M | +206.9% |
| FY2020 | -$49.6M | +41.5% |
| FY2019 | -$84.7M | -371.4% |
| FY2018 | -$18.0M | +66.1% |
| FY2017 | -$53.1M | -195.4% |
| FY2016 | -$18.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026